{"id":44055,"title":"Adherence to Antiretrovial Therapy in Patients with HIV \/ AIDS: Combination Therapy X Conventional Therapy","title_html":"<p>Adherence to Antiretrovial Therapy in Patients with HIV \/ AIDS: Combination Therapy X Conventional Therapy<\/p>","image":{"source":"https:\/\/www.protocols.io\/img\/default_protocol.png","placeholder":"https:\/\/www.protocols.io\/img\/default_protocol.png"},"doi":"dx.doi.org\/10.17504\/protocols.io.bn9xmh7n","doi_status":2,"uri":"adherence-to-antiretrovial-therapy-in-patients-wit-bn9xmh7n","type_id":1,"template_id":1,"published_on":1604150201,"parent_protocols":[],"parent_collections":[],"cited_protocols":[],"version_id":0,"version_data":{"id":"0","code":"bn9xmh7n","parent_id":0,"parent_uri":null,"is_same_owner":false,"has_pending_merge_request":false,"has_approved_merge_request":false},"created_on":1604095323,"modified_on":null,"categories":null,"public":1,"is_unlisted":0,"creator":{"name":"rmsneto_ ","affiliation":null,"affiliations":[],"username":"m4ule152s1y4qle1","note":null,"link":null,"image":{"source":"\/img\/avatars\/013.png","placeholder":"\/img\/avatars\/013.png"},"badges":[{"id":2,"image":{"source":"\/img\/badges\/bronze.svg","placeholder":"\/img\/badges\/bronze.svg"},"name":"Author"}],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"journal":null,"journal_name":null,"journal_link":null,"article_citation":null,"has_versions":0,"link":null,"total_collections":0,"number_of_steps":16,"authors":[{"name":"Poliana Moreira de Medeiros Carvalho","affiliation":"Unijuazeiro","affiliations":[],"username":"w2y2c4x2w213","note":"Dra. Health Sciences","link":null,"image":{"source":"\/img\/avatars\/017.png","placeholder":"\/img\/avatars\/017.png"},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"rmsneto_ ","affiliation":"Unijuazeiro","affiliations":[],"username":"m4ule152s1y4qle1","note":"Graduating in nursing","link":null,"image":{"source":"\/img\/avatars\/013.png","placeholder":"\/img\/avatars\/013.png"},"badges":[],"verified":1,"is_verified_user":true,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false}],"versions":[],"groups":[{"id":12885,"uri":"health-care-applied-to-pharmacotherapy","title":"Health Care Applied to Pharmacotherapy","image":{"source":"https:\/\/www.protocols.io\/img\/group_placeholder.png","placeholder":"https:\/\/www.protocols.io\/img\/group_placeholder.png"},"tech_support":{"email":null,"phone":null,"hide_contact":0,"use_email":0,"url":null},"is_member":1,"request":{"id":12885,"uri":"health-care-applied-to-pharmacotherapy","title":"Health Care Applied to Pharmacotherapy","image":{"source":"https:\/\/www.protocols.io\/img\/group_placeholder.png","placeholder":"https:\/\/www.protocols.io\/img\/group_placeholder.png"},"tech_support":{"email":null,"phone":null,"hide_contact":0,"use_email":0,"url":null},"is_member":1,"description":null,"research_interests":null,"website":null,"location":null,"affiliation":null,"status":{"is_visible":true,"access_level":0},"stats":{"files":[],"total_members":0,"total_followers":0,"total_child_groups":0,"total_parent_groups":0,"has_collaborations":0},"user_status":{"is_member":true,"is_confirmed":true,"is_invited":false,"is_owner":true,"is_admin":false,"is_following":false},"join_link":null,"token":null,"owner":{"name":" ","affiliation":null,"affiliations":[],"username":null,"note":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"is_protocol_requested":0,"is_group_requested":0,"is_my":false,"is_request":false,"is_confirmed":1,"is_declined":0,"requester":{"name":" ","affiliation":null,"affiliation_url":null,"username":null,"link":null},"protocol":{"id":0,"title":"Adherence to Antiretrovial Therapy in Patients with HIV \/ AIDS: Combination Therapy X Conventional Therapy","title_html":"Adherence to Antiretrovial Therapy in Patients with HIV \/ AIDS: Combination Therapy X Conventional Therapy","image":{"source":null,"placeholder":null},"doi":null,"doi_status":0,"uri":"adherence-to-antiretrovial-therapy-in-patients-wit-bn9xmh7n","type_id":1,"template_id":0,"published_on":null,"stats":{"number_of_views":0,"number_of_steps":0,"number_of_bookmarks":0,"number_of_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"is_voted":0},"parent_protocols":[],"parent_collections":[],"cited_protocols":[]},"created_on":1604150203,"resolve_on":0,"resolved_user":{"name":" ","affiliation":null,"affiliations":[],"username":null,"note":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"shared":false}}],"is_owner":1,"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"can_claim_authorship":0,"can_accept_authorship":0,"can_be_copied":1,"can_remove_fork":1,"fork_id":null,"url":"https:\/\/www.protocols.io\/view\/adherence-to-antiretrovial-therapy-in-patients-wit-bn9xmh7n","forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":0,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"guid":"877223D01AFB11EBBA7DADF314FD8157","state_version_id":51,"steps":[{"id":1066583,"guid":"8AD7BD001AFB11EBBA7DADF314FD8157","previous_id":null,"previous_guid":null,"modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"17F74CE71CA341408E07C4CF9CA70EFF","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"BC70EC7B6EA649228CEC90AE79F926C9","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">Adherence to Antiretrovial Therapy in Patients with HIV \/ AIDS: Combination Therapy X Conventional Therapy<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066637,"guid":"0258D1201B7911EB9FC28F8BB050A68F","previous_id":1066583,"previous_guid":"8AD7BD001AFB11EBBA7DADF314FD8157","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"3CA4C9348CD544099E5F933FB4E2A5D7","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"F99A7667AC374EAEB42C055C0083DA29","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><div class = \"justify\" style = \"text-align:center\"><\/div><\/div><div class = \"text-block\">Poliana Moreira de Medeiros Carvalho<\/div><div class = \"text-block\">Pharmaceuticals, PhD by the Postgraduate Program in Health Sciences, ABC Medical School (FMABC), Santo Andr\u00e9, SP, Brazil. https:\/\/orcid.org\/0000-0002-2470-1923<\/div><div class = \"text-block\">Raimundo Monteiro da Silva Neto<\/div><div class = \"text-block\">Nursing Course, University Center of Juazeiro do Norte (UNIJUAZEIRO), Juazeiro do Norte, CE, Brazil.https:\/\/orcid.org\/0000-0001-9949-1740.<\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:center\"><\/div><\/div><div class = \"text-block\">Modesto Leite Rolim Neto<\/div><div class = \"text-block\">Post Doctorate in Public Health from the University of S\u00e3o Paulo - USP. PhD in Health Sciences from the Federal University of Rio Grande do Norte \u2013 UFRN.https:\/\/orcid.org\/0000-0002-7715-5508<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066638,"guid":"2255C0501B7911EB9FC28F8BB050A68F","previous_id":1066637,"previous_guid":"0258D1201B7911EB9FC28F8BB050A68F","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"483A3D627BEC4378B54CAF063BF330E7","order_id":1,"type_id":6,"title":"Section","source":{"title":""}},{"id":1054724,"guid":"541356F59B764D84B5ED2DAF22453C53","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><div class = \"justify\" style = \"text-align:center\"><span style = \"font-weight:bold;\">ABSTRACT<\/span><\/div><\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Introduction<\/span><span>: Low adherence to antiretroviral therapy (TARV) allows increased multidrug resistant viral transmission. <\/span><span style = \"font-weight:bold;\">Objectives:<\/span><span> To evaluate the rates of adherence to combined antiretroviral therapy versus conventional antiretroviral therapy among patients diagnosed with HIV\/AIDS. <\/span><span style = \"font-weight:bold;\">Methods<\/span><span>: Cross-sectional study, conducted in Juazeiro Norte-CE, Brazil. Patients >18 years using TARV for 6 months were included. Data collection took place in 2016 through the instrument (CEAT-VIH), validated in Brazil by RemorMilner-Moskovics; Preussler2007. <\/span><span style = \"font-weight:bold;\">Results<\/span><span>: The prevalence of adherence to TARV was 49 (66.2%), 44 (59.2%) had undetectable viral load and 55 (74.3%) had CD4 + >350 lymphocytes, corroborating the progression of clinical treatment results. <\/span><span style = \"font-weight:bold;\">Conclusion:<\/span><span> The success of TARV depends on the strategy of adherence to the prescribed system. In this study, adherence to combined TARV proved to be higher than conventional antiretroviral therapy, and treatment with a reduced number of pills is likely to represent an improvement in patient quality.<\/span><\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Key-words<\/span><span>: Adherence; Antiretroviral Therapy; HIV\/AIDS.<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066639,"guid":"863C65B01B7911EB926CFF59C89CD3E1","previous_id":1066638,"previous_guid":"2255C0501B7911EB9FC28F8BB050A68F","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"5774AEEA5935439A804E83637D0831A7","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"FE23208EB576451390B5B841EC476110","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">INTRODUCTION <\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066640,"guid":"B91D4CB01B7911EB926CFF59C89CD3E1","previous_id":1066639,"previous_guid":"863C65B01B7911EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"2E8C9073A110455D9EF998B10805E9B1","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"D7535B7523984C698613202A8190FE55","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>The Human Immunodeficiency Virus (HIV) causes Acquired Immunodeficiency Syndrome (AIDS) that affects the patient's immune system, allowing several types of opportunistic diseases <\/span><span style = \"vertical-align:super;\">1<\/span><span>. The development of antiretroviral therapies has given its users a reduction in the morbidity and mortality of people living with HIV \/ AIDS <\/span><span style = \"vertical-align:super;\">2<\/span><span style = \"vertical-align:super;\">.<\/span><\/div><div class = \"text-block\"><span>AIDS is a global health problem that affects indifferently the population in different age groups and socioeconomic classes <\/span><span style = \"vertical-align:super;\">3<\/span><span>. During 2015, in Brazil, 718 thousand people lived with HIV \/ AIDS <\/span><span style = \"vertical-align:super;\">4<\/span><span>, and the populations most affected are those who use drugs, transgender women and homosexuals <\/span><span style = \"vertical-align:super;\">5<\/span><span>. <\/span><\/div><div class = \"text-block\"><span>Since HIV was detected, advances in research have allowed the emergence of new perspectives for improvement in the control and diagnosis of the disease <\/span><span style = \"vertical-align:super;\">6<\/span><span>. Combined antiretroviral therapies started in 1996, formed by the combination of three or more antiretroviral drugs capable of acting at different stages of virus replication and suppressing viral replication and HIV progression <\/span><span style = \"vertical-align:super;\">7<\/span><span>. These therapies have been considered more effective than single drug treatments <\/span><span style = \"vertical-align:super;\">8<\/span><span style = \"vertical-align:super;\">.<\/span><\/div><div class = \"text-block\"><span>Access to antiretrovirals has reduced opportunistic diseases by 50% and mortality rates for people living with HIV <\/span><span style = \"vertical-align:super;\">9<\/span><span>. In addition to reducing the occurrence of opportunistic diseases and improving the quality of life <\/span><span style = \"vertical-align:super;\">10<\/span><span>antiretroviral provides a reduction in virus 11 transmission as low viral load reduces the risk of partner contamination<\/span><span style = \"vertical-align:super;\">12<\/span><span style = \"vertical-align:super;\">.<\/span><\/div><div class = \"text-block\"><span>In Brazil, antiretroviral drugs are distributed free of charge<\/span><span style = \"vertical-align:super;\">13<\/span><span>. According to data published by the Ministry of Health (2012) <\/span><span style = \"vertical-align:super;\">14<\/span><span>Souza, Tib\u00farcio and Koike (2016) <\/span><span style = \"vertical-align:super;\">15<\/span><span>, described that there are 17 drugs used in the treatment of HIV\/AIDS, but the success of these drugs depends on the patient's rate of adherence to treatment<\/span><span style = \"vertical-align:super;\">16<\/span><span>.<\/span><\/div><div class = \"text-block\"><span>In this context, a therapy has been developed in Brazil to replace at least three drugs with just one pill with three active ingredients from different classes of drugs, called Triple Combination Antiretroviral Therapy. The reduction in the amount of pills taken daily is a factor capable of improving the patient's adherence to the drug, providing a treatment that can ensure the reduction of morbidity and mortality of individuals living with HIV\/AIDS. <\/span><span style = \"vertical-align:super;\">17<\/span><span style = \"vertical-align:super;\">.<\/span><\/div><div class = \"text-block\"><span>Adherence of antiretroviral drugs is evaluated through clinical data such as CD4 T lymphocyte count and viral load <\/span><span style = \"vertical-align:super;\">18<\/span><span>. Calvetti et al (2016) <\/span><span style = \"vertical-align:super;\">19<\/span><span> evaluating Remor's; Milner-Moskovics's; Preussler's studies (2007) <\/span><span style = \"vertical-align:super;\">20<\/span><span> identified that adherence to treatment is a result of individual life with the need to maintain the use of antiretrovirals as prescribed by the doctor in his daily routine, while non adherence reflects a need for public health concerns, a threat to the complexity of long-term treatment and the presentation of various side effects <\/span><span style = \"vertical-align:super;\">18<\/span><span style = \"vertical-align:super;\">.<\/span><\/div><div class = \"text-block\"><span>People living with HIV achieve good rates of adherence with the use of antiretrovirals and have better quality of life <\/span><span style = \"vertical-align:super;\">19<\/span><span>. Considering the development of Triple Combination Antiretroviral Therapy, in which the patient uses only one drug with three active principles, it is necessary to assess whether this type of treatment is capable of ensuring patient compliance.<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066641,"guid":"CC3D8A301B7911EB926CFF59C89CD3E1","previous_id":1066640,"previous_guid":"B91D4CB01B7911EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"36076EAEADC543089BAF7B65BDB9E3C5","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"5AC628DC7491435081D3008A19B470E7","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">METHOD<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066642,"guid":"E2A578A01B7911EB926CFF59C89CD3E1","previous_id":1066641,"previous_guid":"CC3D8A301B7911EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"9A28569872AD420EA5B638CE5E84F314","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"2D2E8E577A104D1DAACD7D0ADCF18579","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">This is a descriptive, cross-sectional and retrospective study with a quantitative and qualitative approach at the Infectology Center of the city of Juazeiro do Norte, Brazil, with patients diagnosed with HIV \/ AIDS undergoing conventional combination therapy. <\/div><div class = \"text-block\"><span>The Infectology Center attends approximately 900 patients living in 31 cities, corresponding to the states of Cear\u00e1, Pernambuco and Para\u00edba. A total of 74 patients, 18 years old or older, were treated with antiretroviral drugs for at least 6 months. Pregnant women, parturient women, and elderly people over 65 years of age were excluded from the study because they presented a different pharmaco-therapeutic behavior. The data collection was done through the application of an adapted questionnaire, Cuestionario para La Evaluaci\u00f3n de La Adhesi\u00f3n al TratamientoAntirretroviral (CEAT-VIH), validated in Brazil by Remor, Millner and Preussler (2007) <\/span><span style = \"vertical-align:super;\">20<\/span><span>, as a method to assess the degree of adherence to prescribed drug treatment.<\/span><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:justify\">The research was submitted to the ethics committee of Faculdade de Juazeiro do Norte - FJN, according to resolution 510\/2016, CAAE protocol: 53825116.3.0000.5624, number: 1.522.985.<\/div><style>\n\t\t\t\t\t\t\t  .justify:after {\n\t\t\t\t\t\t\t    content: \"\";\n\t\t\t\t\t\t\t    display:inline-block;\n\t\t\t\t\t\t\t    width: 100%;\n\t\t\t\t\t\t\t  }\n\t\t\t\t\t\t\t<\/style><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:justify\">The survey participants were approached individually at the pharmacy office at the time of distribution of their antiretroviral drugs, when the data were collected through the questionnaire applied directly to the patient, as well as using the medical records collecting laboratory data from patients. The ethical guidelines followed the criteria for the application of the informed consent form (TCLE), an indispensable document according to resolutions 466\/12 and 510\/16, which seeks to ensure ethics in research with human beings.<\/div><style>\n\t\t\t\t\t\t\t  .justify:after {\n\t\t\t\t\t\t\t    content: \"\";\n\t\t\t\t\t\t\t    display:inline-block;\n\t\t\t\t\t\t\t    width: 100%;\n\t\t\t\t\t\t\t  }\n\t\t\t\t\t\t\t<\/style><\/div><div class = \"text-block\">The research presented a minimum risk of embarrassment to the participants, which was minimized by the application of an individual questionnaire orally, in a pharmaceutical office, ensuring total confidentiality of the information provided and the anonymity of their identity. On the other hand, the research aimed to benefit the patients, identifying the reasons that lead to non adherence to antiretroviral treatments, since there is constant care with the lives of patients diagnosed with HIV \/ AIDS, providing future interventions for improvements in pharmacological adherence rates. The data were analyzed by the SSPS 22.0 program, through descriptive statistics.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066643,"guid":"EC5331801B7911EB926CFF59C89CD3E1","previous_id":1066642,"previous_guid":"E2A578A01B7911EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"6383906CA69C479081F62D2999279232","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"D37A65DB1D634B63A0E774C1E2FABED8","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">RESULTADOS E DISCUSS\u00c3O<\/span><span style = \"font-weight:bold;\"><\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066644,"guid":"F1E372E01B7911EB926CFF59C89CD3E1","previous_id":1066643,"previous_guid":"EC5331801B7911EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"071EC7CB15164E79B90BBD280813B178","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"DFE641824A31424384601D937B54C754","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>According to Obreli-Neto et al (2012) <\/span><span style = \"vertical-align:super;\">21<\/span><span>, adherence to therapy is the degree of commitment that the user has to follow a pharmacological treatment, which will modify some requirements in their lifestyle, with the guidance of health professionals in order to achieve the coterautic success of dapharma. Corroborating with the answers to the questionnaires, 70 (94.60%) of the participants in this study had a satisfactory degree of adherence to ART therapy and 4 (5.40%) had a moderate adherence, indicating that they were adherent to the treatment. Ribeiro et al (2010) <\/span><span style = \"vertical-align:super;\">22<\/span><span>, emphasized that adherence to ART has as a parameter to minimize the prolongation of signs and symptoms of the disease, being essential the participation of health professionals and their patients in clinics, since the degree of adherence to ART is positively correlated with clinical results.<\/span><\/div><div class = \"text-block\"><span>In view of the adherence rates <\/span><span style = \"font-weight:bold;\">(Figure 1)<\/span><span> measured in patients with ART, we found satisfactory adherence to conventional therapy, although it had a dose complexity that is a vulnerability factor for low pharmacological adherence due to the amount of drugs to be administered in this therapy. In contrast, in combined therapy it was evaluated as satisfactory due to its posological convenience, since the amount of pills used in each injection is reduced.<\/span><\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Figura 1: <\/span><span>Distribui\u00e7\u00e3o de pacientes com HIV, grau de ader\u00eancia \u00e0 terapia ART.<\/span><\/div><div style = \"text-align :; float : ;\"><img style = \"\" src = \"blob:https:\/\/www.protocols.io\/d1505ae2-f1f7-4d51-8c47-cd7dee729738\" \/><\/div><div class = \"text-block\">* N: 74 Patients (Total patients).<\/div><div class = \"text-block\">Source: Patients treated in the Infectology Center (DST).<\/div><div class = \"text-block\"><span>Osorio et al (2015) <\/span><span style = \"vertical-align:super;\">23<\/span><span>indicated that before HAART, patients had a 78% prevalence of deaths annually, but with the introduction of the antiretroviral drug combination after a cohort study in France, this percentage gradually drops by about 23-55 %. Meanwhile, Batista et al (2014) <\/span><span style = \"vertical-align:super;\">24<\/span><span>, reports that drug abuse, alcoholism and the irrational application of antiretrovirals are one of the determining factors for secondary infections, as well as reducing the rate of pills and adherence to treatment.<\/span><\/div><div class = \"text-block\"><span>RemorMilner-Moskovics & Preussler (2007) <\/span><span style = \"vertical-align:super;\">20<\/span><span>, observed that the complexity of therapy can influence the degree of adherence. However, patients who took more pills had a higher viral load (statistically significant ratio), and may indicate possible difficulties in following the treatment. The commitment to treatment, clarification by the health professional, incentives and confidence on the part of family members are other factors that increase the patient's adherence to treatment <\/span><span style = \"vertical-align:super;\">25<\/span><span style = \"vertical-align:super;\">.<\/span><\/div><div class = \"text-block\"><span>It was evidenced that the combined therapy used in patients with satisfactory degree of adherence showed a reduction in viral load <\/span><span style = \"font-weight:bold;\">(Figure 2)<\/span><span> and increased TCD4 + lymphocytes <\/span><span style = \"font-weight:bold;\">(Figure 3)<\/span><span>, which demonstrates a clinical correlation with the expected results, confirming the pharmacotherapeutic success. These data confirm a reduction in the public health problem, which is linked to a decrease in viral transmission and opportunistic diseases such as tuberculosis, pneumonia, candidiasis, cryptococcosis, toxoplasmosis and others, affecting half of the world population.<\/span><\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Figure 2: <\/span><span>Viral load<\/span><\/div><div style = \"text-align :; float : ;\"><img style = \"\" src = \"blob:https:\/\/www.protocols.io\/a989b663-6086-4f6e-b7e2-827de84716ca\" \/><\/div><div class = \"text-block\">* N: 74 Patients (Total patients).<\/div><div class = \"text-block\">Source: Patients treated in the Infectology Center (DST).<\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Figure 3: <\/span><span>Lymphocyte count<\/span><\/div><div style = \"text-align :; float : ;\"><img style = \"\" src = \"blob:https:\/\/www.protocols.io\/14e79ea2-409f-498d-93e5-682e99547bc4\" \/><\/div><div class = \"text-block\">* N: 74 Patients (Total Patients).<\/div><div class = \"text-block\">Source: Patients treated in the Infectology Center (DST).<\/div><div class = \"text-block\"><span>Ilias <\/span><span style = \"font-style:italic;\">et al<\/span><span> (2011) <\/span><span style = \"vertical-align:super;\">26<\/span><span>,claim that there are several studies that correlate non adherence to ART with large amounts of pills, drugs and daily doses to be taken. However, our study conducted at the Center for Infectious Diseases STD\/AIDS in Juazeiro do Norte-CE did not show this association. This significant adherence can be justified by the severity of the disease, making the patient more responsible for following the pharmacological adherence <\/span><span style = \"font-weight:bold;\">(Figures 2 and 3).<\/span><\/div><div class = \"text-block\"><span>From a sociodemographic perspective, the degree of adherence was not influenced. Remor Milner-Moskovics and Preussler (2007) <\/span><span style = \"vertical-align:super;\">20<\/span><span>(emphasized that the adherence does not seem to be influenced by the socio-demographic characteristics of the sample. These factors have been addressed in other studies, such as Jordan et al (2000) <\/span><span style = \"vertical-align:super;\">27<\/span><span> and Lignani Jr. et al (2001) <\/span><span style = \"vertical-align:super;\">28<\/span><span> that did not consider the socioeconomic status as a good predictor of adherence to treatment. Lemos et al (2016) <\/span><span style = \"vertical-align:super;\">29<\/span><span> stated that there are more important factors in these studies capable of influencing the degree of adherence, except in places where there is extreme poverty.<\/span><\/div><div class = \"text-block\"><span>In the classification of the intensity of the side effects, it was evidenced that 28 patients (37.84%) reported that the side effects were not intense. Despite the significant effects, for Romeo et al(2012) <\/span><span style = \"vertical-align:super;\">30<\/span><span> the difficulties related to side effects are insufficient to explain non adherence to treatment, since 72.9% of the patients interviewed considered the side effects insignificant <\/span><span style = \"font-weight:bold;\">(Figure 4).<\/span><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:center\"><span style = \"font-weight:bold;\">Figure 4: <\/span><span>Distribution of HIV patients, Side effects.<\/span><\/div><\/div><div style = \"text-align :; float : ;\"><img style = \"\" src = \"blob:https:\/\/www.protocols.io\/a1bc7a95-5e89-4445-8cd3-ce7521f66abc\" \/><\/div><div class = \"text-block\">* N: 74 Pacientes (Total de Pacientes).<\/div><div class = \"text-block\">Fonte: Pacientes tratados no Centro de Infectologia (DST).<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066645,"guid":"116EDB901B7A11EB926CFF59C89CD3E1","previous_id":1066644,"previous_guid":"F1E372E01B7911EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"C6F3FCE4B6F0475FB442AA3E667D544E","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"67C8D5E5AA2B40AC82FB628617950169","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">CONCLUSION <\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066646,"guid":"17AF33101B7A11EB926CFF59C89CD3E1","previous_id":1066645,"previous_guid":"116EDB901B7A11EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"9B25B82513F5488A977D6E2459813BED","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"FFC41F09DA5A4EA3AAB6C4A63C2AB414","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Patients who underwent combined therapy achieved a degree of adherence of 64.9%, which was higher than the degree of adherence to conventional antiretroviral therapy, which showed a result of 29.7%. The results of the diagnoses were correlated with the degree of adherence shown in the result of this research. We can observe that the combination of drugs allows the adherence of drug therapy and that the possibility of side effects was insufficient to identify the lack of adherence to therapy.<\/div><div class = \"text-block\">Adherence to medication is a phenomenon strongly linked to the experience of treatment and may change over time, as changes may appear in this period. Difficulties occur during the whole treatment, with moments of greater or lesser adherence for all patients, besides the availability of the health team, in this case, the doctor was only available three times a week.<\/div><div class = \"text-block\">The lack of qualified professionals can lead patients not to adhere properly to the treatment. Therefore, there must be a shared care between the health team and family members, keeping in mind that, to achieve an effective treatment, an alliance must be sought with the patients, emphasizing the importance and necessity of adherence to the treatment for therapeutic success and quality of life.<\/div><div class = \"text-block\">Even with positive results increasingly achieved with the development of antiretroviral treatments, it is necessary to continue research, not only to prevent the spread of HIV\/AIDS, but also to develop treatments that show an increasing degree of adherence, quality of life and life expectancy for patients.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066647,"guid":"238DFCC01B7A11EB926CFF59C89CD3E1","previous_id":1066646,"previous_guid":"17AF33101B7A11EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"384A6046964D4E48B9236906C1D96739","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"C32EFABC3A734A15B00231C2F5C492A6","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">FINANCING<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066648,"guid":"2957EBC01B7A11EB926CFF59C89CD3E1","previous_id":1066647,"previous_guid":"238DFCC01B7A11EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"22E31A19CF1F404FBB12120FDC5ABB38","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"4F6E0F58585E48F5B5BFD6CB61097562","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">ACKNOWLEDGEMENTS<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066649,"guid":"349BFC101B7A11EB926CFF59C89CD3E1","previous_id":1066648,"previous_guid":"2957EBC01B7A11EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"3CA3F87CF3E74B43B01D910D1F9920C3","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"8CF287FA879F45689F4DC8508E94AD85","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">DECLARATION OF COMPETING INTEREST<\/span><span style = \"font-weight:bold;\">\n<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066650,"guid":"3ABC6F801B7A11EB926CFF59C89CD3E1","previous_id":1066649,"previous_guid":"349BFC101B7A11EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"B450619F5DFB484AB1E3B6133142159F","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"F23A203550564AEB8960BB176910B0C0","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span style = \"font-weight:bold;\">REFERENCES<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1066651,"guid":"40F6D3901B7A11EB926CFF59C89CD3E1","previous_id":1066650,"previous_guid":"3ABC6F801B7A11EB926CFF59C89CD3E1","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"72367022C06E49DF922D7A2062F379DA","order_id":1,"type_id":6,"title":"Section","source":{"title":"Manuscript"}},{"id":1054724,"guid":"9FBA9DAF314F46029949D5E84A33489B","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">1. Costa RHS, Nelson ARC, Da Costa Prado NC, Rodrigues EHF, Da Silva RAR. Nursing diagnoses and their components in acquired immune deficiency syndrome patients. ACTA Paul Enferm. 2016;29(2):146-153. doi:10.1590\/1982-0194201600021.<\/div><div class = \"text-block\">2. Medeiros, Aur\u00e9lio M, de Ara\u00fajo Tinoco Cabral G, Silva Dantas M. Qualidade de vida, fatores socioecon\u00f4micos e cl\u00ednicos e pr\u00e1tica de exerc\u00edcio f\u00edsico em pessoas vivendo com HIV\/aids. Rev Saude Publica. 2017;51:1-8. doi:10.1590\/S1518-8787.2017051006266.<\/div><div class = \"text-block\">3. Leal NSB, Co\u00ealho AEL. Representa\u00e7\u00f5es sociais da AIDS para estudantes de Psicologia. Fractal Rev Psicol. 2016;28(1):9-16. doi:10.1590\/1984-0292\/918.<\/div><div class = \"text-block\">4. Gouv\u00eaa ADFTB, MacHado DM, Beltr\u00e3o SCDV, Carmo FB Do, Mattar RHGM, Succi RCDM. Hipertens\u00e3o portal n\u00e3o cirr\u00f3tica em adolescente infectado pelo v\u00edrus da imunodefici\u00eancia humana (HIV). Rev Paul Pediatr. 2015;33(2):246-250. doi:10.1016\/j.rpped.2014.09.001.<\/div><div class = \"text-block\">5. UNAIDS. Arquivos relat\u00f3rio lacuna de preven\u00e7\u00e3o - UNAIDS Brasil. https:\/\/unaids.org.br\/tag\/relatorio-lacuna-de-prevencao\/. Published 2017. Accessed July 27, 2020.<\/div><div class = \"text-block\">6. Pagiola IC, Paiva ALC, De Aguiar GB, Penalva De Oliveira AC, Conti MLM, Gagliardi RJ. Cerebral aneurysms associated with human immunodeficiency virus in adults: Literature review and new perspectives. Rev Assoc Med Bras. 2016;62(1):85-89. doi:10.1590\/1806-9282.62.01.85.<\/div><div class = \"text-block\">7. Fernandes NM, Hennington \u00c9A, Bernardes J de S, Grinsztejn BG. Vulnerability to HIV infection in serodiscordant couples in Rio de Janeiro, Brazil. Cad Saude Publica. 2017;33(4):e00053415. doi:10.1590\/0102-311X00053415.<\/div><div class = \"text-block\">8. Segurado AC, Cassenote AJ, De Albuquerque Luna E. Sa\u00fade nas metr\u00f3poles-Doen\u00e7as infecciosas. Estud Avancados. 2016;30(86):29-49. doi:10.1590\/S0103-40142016.00100003.<\/div><div class = \"text-block\">9. Azeredo TB, Oliveira MA, Santos-Pinto CDB, Miranda ES, Osorio-de-Castro CGS. Sustentabilidade da provis\u00e3o de medicamentos ARV em pa\u00edses em desenvolvimento: Modelo de avalia\u00e7\u00e3o com base na hist\u00f3ria do programa. Cienc e Saude Coletiva. 2017;22(8):2581-2594. doi:10.1590\/1413-81232017228.29472016.<\/div><div class = \"text-block\">10. Mangilli LD, Sassi FC, Stafocher TS, Andrade CRF de. Atua\u00e7\u00e3o fonoaudiol\u00f3gica em pacientes com s\u00edndrome da imunodefici\u00eancia adquirida e queixa de degluti\u00e7\u00e3o \u2013 an\u00e1lise retrospectiva de prontu\u00e1rios. Audiol - Commun Res. 2016;21(0):1620-1621. doi:10.1590\/2317-6431-2015-1620.<\/div><div class = \"text-block\">11. Guedes-Granzotti RB, Fukuda MTH, Silva K da, Dornelas R, Domenis DR, Takayanagui OM. Linguagem oral e escrita de crian\u00e7as soropositivas para o HIV: um acompanhamento longitudinal. Audiol - Commun Res. 2017;22(0). doi:10.1590\/2317-6431-2017-1852.<\/div><div class = \"text-block\">12. da Silva LAV, Duarte FM, Netto GRA. Sociabilidades \u201cpositivas\u201d em rede: Narrativas de jovens em torno do HIV\/Aids e suas tens\u00f5es cotidianas. Physis. 2017;27(2):335-355. doi:10.1590\/s0103-73312017000200009.<\/div><div class = \"text-block\">13. Piccoli NJ, De Brito MA, De Castilho SR. Assessment of pharmaceutical services in HIV\/AIDS health units in the city of Niter\u00f3i, Brazil. Brazilian J Pharm Sci. 2017;53(2):16113. doi:10.1590\/s2175-97902017000216113.<\/div><div class = \"text-block\">14. Brasil. Treatment for HIV and AIDS: Medicines. 2012.<\/div><div class = \"text-block\">15. Souza G de O, Tib\u00farcio AACM, Koike MK. Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil. Med Express. 2016;3(3). doi:10.5935\/medicalexpress.2016.03.05.<\/div><div class = \"text-block\">16. Santos WM Dos, Secoli SR, Padoin SM de M. Potential drug interactions in patients given antiretroviral therapy. Rev Lat Am Enfermagem. 2016;24:e2832. doi:10.1590\/1518-8345.1193.2832.<\/div><div class = \"text-block\">17. Brasil. Departamento de Doen\u00e7as de Condi\u00e7\u00f5es Cr\u00f4nicas e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis | Portal sobre aids, infec\u00e7\u00f5es sexualmente transmiss\u00edveis e hepatites virais. http:\/\/www.aids.gov.br\/pt-br. Published 2016. Accessed July 27, 2020.<\/div><div class = \"text-block\">18. Foresto JS, Melo ES, Costa CRB, Antonini M, Gir E, Reis RK. Ades\u00e3o \u00e0 terap\u00eautica antirretroviral de pessoas vivendo com HIV\/aids em um munic\u00edpio do interior paulista. Rev Gauch Enferm. 2017;38(1):e63158. doi:10.1590\/1983-1447.2017.01.63158.<\/div><div class = \"text-block\">19. Calvetti P\u00dc, Giovelli GRM, Gauer GJC, de Moraes JFD. N\u00edveis de ansiedade, estresse percebido e suporte social em pessoas que vivem com HIV\/AIDS. Psicol Teor e Pesqui. 2016;32(4):1-4. doi:10.1590\/0102.3772e324317.<\/div><div class = \"text-block\">20. Remor E, Milner-Moskovics J, Preussler G. Adapta\u00e7\u00e3o brasileira do \u201cCuestionario para la Evaluaci\u00f3n de la Adhesi\u00f3n al Tratamiento Antiretroviral.\u201d Rev Saude Publica. 2007;41(5):685-694. doi:10.1590\/s0034-89102006005000043.<\/div><div class = \"text-block\">21. OBRELI-NETO. M\u00e9todos de avalia\u00e7\u00e3o de ades\u00e3o \u00e0 farmacoterapia. 2012.<\/div><div class = \"text-block\">22. Ribeiro AC, De Paula CC, Neves ET, Padoin SMDM. PERFIL CL\u00cdNICO DE ADOLESCENTES QUE T\u00caM AIDS. Cogitare Enferm. 2010;15(2). doi:10.5380\/ce.v15i2.17858.<\/div><div class = \"text-block\">23. Osorio J, \u00c1lvarez D, Barreto-Mora J, et al. Pulmonary infections in patients with HIV, 20 years after combined antiretroviral therapy. What has changed? Infectio. 2016;20(3):180-189. doi:10.1016\/j.infect.2015.08.002.<\/div><div class = \"text-block\">24. Batista J d. AL, de Albuquerque M de FPM, Santos ML, et al. Associa\u00e7\u00e3o entre tabagismo e o uso de crack com a descontinuidade da terapia antirretroviral combinada em Recife, Pernambuco, Brasil. Rev Inst Med Trop Sao Paulo. 2014;56(2):127-132. doi:10.1590\/S0036-46652014000200007.<\/div><div class = \"text-block\">25. Carvalho ALM, Leopoldino RWD, da Silva JEG, da Cunha CP. Ades\u00e3o ao tratamento medicamentoso em usu\u00e1rios cadastrados no Programa Hiperdia no munic\u00edpio de Teresina (PI). Cienc e Saude Coletiva. 2012;17(7):1885-1892. doi:10.1590\/S1413-81232012000700028.<\/div><div class = \"text-block\">26. M\u00e9rcia I. Ades\u00e3o \u00e0 terapia antirretroviral de portadores do v\u00edrus da imunodefici\u00eancia humana atendidos em um ambulat\u00f3rio da cidade de Mar\u00edlia, S\u00e3o Paulo. https:\/\/repositorio.unesp.br\/handle\/11449\/141342. Published 2011. Accessed July 27, 2020.<\/div><div class = \"text-block\">27. Jordan M da S, Lopes JF, Okazaki E, Komatsu CL, Nemes MIB. Ader\u00eancia ao tratamento anti-retroviral em AIDS: revis\u00e3o da literatura m\u00e9dica. T\u00e1 dif\u00edcil engolir? Experi\u00eancias ades\u00e3o ao Trat anti-retroviral em S\u00e3o Paulo. 2000.<\/div><div class = \"text-block\">28. J\u00fanior LL, Greco DB, Carneiro M. Assessment of the compliance to antiretroviral drugs among HIV\/AIDS patients. Rev Saude Publica. 2001;35(6):495-501. doi:10.1590\/S0034-89102001000600001.<\/div><div class = \"text-block\">29. Lemos L de araujo, Fiuza MLT, Reis RK, Ferre AC, Gir E, Galv\u00e3o MTG. Ades\u00e3o aos antirretrovirais em pessoas com coinfec\u00e7\u00e3o pelo v\u00edrus da imunodefici\u00eancia humana e tuberculose. 2016.<\/div><div class = \"text-block\">30. ROMEU, A G, TAVARES MM, CARMO CP, MAGALH\u00c3ES, K. do. N; NOBRE ACL, MATOS V. de. Avalia\u00e7\u00e3o da Ades\u00e3o a Terapia Antirretroviral de Pacientes portadores de HIV. RevBrasFarmHospServ Sa\u00fade. 2012.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0}],"document":null,"materials":[],"description":null,"changed_on":1604150201}